Your generous year-end donation will be matched $1 for $1 DONATE
In “Adult Conversation on High-Priced Drugs? Don’t Hold Your Breath (But Hang in There)…,” Rob Cunningham provided a summary of a recent event held by the Brookings Institution that examined the cost and value of biomedical innovation. The event focused predominately on the controversial price of Sovaldi, a drug that has a cure rate of over 90% […]
This week, several articles caught our eye: Amy Berman shared her own experience “Choosing Wisely” when she opted for a single dose of radiation therapy to alleviate pain from bone metastases, instead of a course of 10 treatments. The Kaiser Family Foundation reported that 89% of uninsured individuals polled are not aware that the next open […]
This week, in an article by science and medicine reporter Matthew Herper titled “A Drug Regrew a Little Girl’s Missing Bones. How Much Should That Cost?” from Forbes caught our eye. Evie Elsaesser was born with a rare, life-threatening genetic disease causing low levels of hypophophatasia— a chemical important for bone hardening—in her blood. Although […]
What caught our eye this week was extensive coverage of Dr. Atul Gawande’s new book, Being Mortal: Medicine and what Matters in the End. In it, he examines end-of-life care in our country, and he weaves in personal stories from his own family and his patients, as well as interviews of hundreds of patients, families, […]
This week, coverage of the release of data on payments by drug and device manufacturers to physicians caught our eye. The Centers for Medicare and Medicaid Services (CMS) released the first round of Open Payments data as mandated by the Physician Payments Sunshine Act provisions of the Affordable Care Act in 2010. The Sunshine Act […]
In a Health Affairs blog post entitled, “Reconceptualizing Health and Health Care: Why Our Cancer Care Delivery System Is In Crisis,” Carolyn Payne and William Dale suggest that the health care system should look at patients more holistically, rather than focus on a single disease such as cancer. They cite last year’s report by the […]
Are we finally ready to address the repeated recommendations in these series of reports and to make it possible for our healthcare system, providers of care, and our religious leaders to be more ready to assist people in making difficult decisions about how to die well? One of the articles that caught our eye this […]
There are as many questions as there are differences of opinion about what constitutes the best evidence when it comes to appropriate cancer screening and then appropriate treatment once a diagnosis of cancer is made. Patients who read about current research findings face the dilemma of sorting through these differences of opinion and considering how […]
In The New York Times article, “Coverage for End-of-Life Talks Gaining Ground,” Pam Belluck writes about efforts to reimburse physicians for having difficult but critically important discussions with patients about the kind of care they wish to receive at the end of life. “Five years after it exploded into a political conflagration over ‘death panels,’ […]
In Elana Gordon’s segment with NPR titled, “Hello, May I Help You Plan Your Final Months?” she reports on the work of Vital Decisions, a company that provides counseling via phone to beneficiaries of participating insurance companies in efforts to facilitate discussions about end-of-life care. Counselors often cold-call patients after attempts to reach them via postal […]
Survivorship Champions is a program for all clinicians and researchers, both oncology and primary care, who are interested in improving survivorship care and primary care’s role in caring for cancer survivors.
The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.
NCCS represents the millions of Americans who share a common experience – living with, through and beyond a cancer diagnosis. By sharing your story of how you have been touched by cancer, you are supporting the national cancer survivorship movement.
Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action
National Coalition for Cancer Survivorship
8455 Colesville Road | Suite 930 | Silver Spring, MD 20910
info@canceradvocacy.org | (877) NCCS-YES
Privacy Policy | Terms and Conditions
Copyright © 1995-2024 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.
Your gift to NCCS helps build a brighter, more inclusive future
for cancer survivors everywhere.
Now through December 31 your gift to NCCS will be doubled!
Text NCCS to 24365
OR
"*" indicates required fields
"*" indicates required fields
Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.
Founder
Northeast Regional Cancer Institute
“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”
—Karen M. Saunders
President, Northeast Regional Cancer Institute